A 24 month, randomized, controlled, study to evalute the efficacy and safety of concentration-controlled everolimus plus reduced tacrolimus in recipients of living donor liver transplants.
2020-07-04
عنوان الدراسة
A 24 month, randomized, controlled, study to evalute the efficacy and safety of concentration-controlled everolimus plus reduced tacrolimus in recipients of living donor liver transplants.
داعم الدراسة
Novartis
دواء الدراسة
Everolimus / reduced tacrolimus / Tacrolimus
رقم بروتوكول الدراسة
CRAD001H2307
حالة الدراسة
Ongoing
موقع الدراسة
King Faisal Specialist Hospital and Research Center (Riyadh)
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。